文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

2015年美国前往乙肝高或中流行国家的≥18岁成人乙肝疫苗接种覆盖率

Hepatitis B vaccination coverage among adults aged ≥18 years traveling to a country of high or intermediate endemicity, United States, 2015.
PubMed 文献 · Vaccine · 2018-04-28

基于2015年美国国家健康访谈调查数据,分析前往乙肝高或中流行国家的≥18岁成人乙肝疫苗接种覆盖率。报告旅行者中至少接种1剂次覆盖率为38.6%,完成≥3剂次系列接种率为31.7%,均显著高于非旅行者的25.9%和21.2%(P<0.05)。作者结论为尽管旅行与接种可能性较高相关,但成人旅行者接种覆盖率仍低。

要点

  • 2015年报告前往乙肝高或中流行国家的≥18岁成人中,至少1剂次乙肝疫苗接种覆盖率为38.6%。
  • 该人群完成≥3剂次系列接种率为31.7%,非旅行者分别为25.9%和21.2%(P<0.05)。
  • 作者建议医疗服务提供者询问患者旅行计划并推荐和提供旅行相关疫苗接种或转诊。

核心结论

  • 尽管前往乙肝高或中流行国家与较高的乙肝疫苗接种可能性相关,但成人旅行者中乙肝疫苗接种覆盖率仍低。
  • 医疗服务提供者应询问患者旅行计划,推荐并提供旅行相关疫苗接种,或将患者转诊至其他接种点。

研究设计与样本

  • 分析2015年美国国家健康访谈调查(NHIS)数据,纳入报告前往乙肝高或中流行国家的≥18岁成人。
  • 采用多变量logistic回归和预测边际分析识别与乙肝疫苗接种独立相关的因素。

主要发现

  • 2015年报告前往乙肝高或中流行国家的≥18岁成人中,至少1剂次乙肝疫苗接种覆盖率为38.6%,非旅行者为25.9%,旅行者显著更高。
  • 旅行者完成≥3剂次系列接种率为31.7%,非旅行者为21.2%(P<0.05)。
  • 多变量分析中,所有受访者中旅行状态与乙肝疫苗接种覆盖率和系列完成显著相关。
  • 旅行者中与接种(≥1剂次和≥3剂次)独立相关的其他特征包括年龄、种族/族裔、教育水平、美国居住时长、过去一年医生接触次数、是否曾检测HIV以及医护人员身份。

临床怎么用

  • 作者建议医疗服务提供者询问患者旅行计划,推荐并提供旅行相关疫苗接种,或将患者转诊至其他接种点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Persons from the United States who travel to developing countries are at substantial risk for hepatitis B virus (HBV) infection. Hepatitis B vaccine has been recommended for adults at increased risk for infection, including travelers to high or intermediate hepatitis B endemic countries. PURPOSE: To assess hepatitis B vaccination coverage among adults ≥18 years traveling to a country of high or intermediate endemicity from the United States. METHODS: Data from the 2015 National Health Interview Survey (NHIS) were analyzed to determine hepatitis B vaccination coverage (≥1 dose) and series completion (≥3 doses) among persons aged ≥18 years who reported traveling to a country of high or intermediate hepatitis B endemicity. Multivariable logistic regression and predictive marginal analyses were conducted to identify factors independently associated with hepatitis B vaccination. RESULTS: In 2015, hepatitis B vaccination coverage (≥1 dose) among adults aged ≥18 years who reported traveling to high or intermediate hepatitis B endemic countries was 38.6%, significantly higher compared with 25.9% among non-travelers. Series completion (≥3 doses) was 31.7% and 21.2%, respectively (P < 0.05). On multivariable analysis among all respondents, travel status was significantly associated with hepatitis B vaccination coverage and series completion. Other characteristics independently associated with vaccination (≥1 dose, and ≥3 doses) among travelers included age, race/ethnicity, educational level, duration of US residence, number of physician contacts in the past year, status of ever being tested for HIV, and healthcare personnel status. CONCLUSIONS: Although travel to a country of high or intermediate hepatitis B endemicity was associated with higher likelihood of hepatitis B vaccination, hepatitis B vaccination coverage was low among adult travelers to these areas. Healthcare providers should ask their patients about travel plans and recommend and offer travel related vaccinations to their patients or refer them to alternate sites for vaccination.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Lu PJ, O'Halloran AC, Williams WW, et al. Hepatitis B vaccination coverage among adults aged ≥18 years traveling to a country of high or intermediate endemicity, United States, 2015. Vaccine. 2018. PMID: 29716773. doi:10.1016/j.vaccine.2018.03.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。